His case was considered a milestone for #MeToo, in which women accused hundreds in entertainment, media, politics and other fields of sexual misconduct
Pfizer Inc and its German partner BioNTech said on Thursday that their Omicron-adapted Covid-19 vaccine booster generated a strong immune response against the currently circulating BA.5 and the BA.4 subvariants of Omicron.
The companies said data from a trial in adult patients showed that the booster dose led to a substantial increase in neutralising antibody levels against the BA.4/BA.5 variants.
Omicron-tailored shots made by Pfizer and Moderna Inc have already been greenlit by several countries, including in the United States for adults and, more recently, for children as young as 5 years.
But, that US authorisation was based on the safety and effectiveness of the original vaccine, and not the BA.4/BA.5-tailored shots.
The preliminary data on Thursday also suggested that the bivalent vaccine was likely to provide better protection against the Omicron subvariants than the original vaccine.
His case was considered a milestone for #MeToo, in which women accused hundreds in entertainment, media, politics and other fields of sexual misconduct
Well-known communication expert Maha Abouelenein on what it takes to thrive in the age of social media
From cultural events, and culinary delights to outdoor adventures, here's a line-up of thrilling activities to make your weekend exciting
'The rom-com garnered $219 million worldwide after its premiere in December
The guitar will be auctioned on May 29 at the Hard Rock Cafe in New York
Fitness enthusiast Sarah Lindsay shares insights on what it takes to embark on a fitness journey and sustain it amidst a busy lifestyle
Such platforms help women to re-enter the workforce by equipping them with new-age skills, upskilling, polishing their interviewing skills and revamping their resumes
Official autism-friendly in-flight certification is in the works, possibly used by other airlines